Formulary tier : Formularies with tiers place drugs into groups mostly based on cost
Occurred in 8.8% of participants on 9 mg and 20.9% on 12 mg, compared to 0.7% on placebo Dose-dependent (higher dose, higher risk) Generally described as mild Rarely led to discontinuation Why this matters: Dysesthesia was not reported in the Phase 2 trial
Do not split, crush, chew, or dissolve in any solution Do not take more than one tablet per day *The safety and effectiveness of Wegovy tablets have not been established in pediatric patients
Patients should also understand hand hygiene, dose measurement, injection timing, needle handling, and sharps disposal
Compounding occurs at licensed 503A pharmacies under strict quality standards
It involves chronic inflammation of the airways, which leads to symptoms such as shortness of breath, chest tightness, wheezing, and coughing